Tie-2, G-CSF, and Leptin as Promising Diagnostic Biomarkers for Endometrial Cancer: A Pilot Study
Preoperative determination of the extent of endometrial cancer (EC) would avoid the complications associated with radical surgery. Screening of patients’ plasma biomarkers might enable a more precise diagnosis of EC and a tailored treatment approach. This prospective case-control monocentric pilot s...
Main Authors: | Luka Roškar, Teja Klančič, Tamara Knific, Tea Lanišnik Rižner, Špela Smrkolj |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/4/765 |
Similar Items
-
Data on expression of genes involved in estrogen and progesterone action, inflammation and differentiation according to demographic, histopathological and clinical characteristics of endometrial cancer patients
by: Maša Sinreih, et al.
Published: (2017-06-01) -
The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer
by: Mahecha AM, et al.
Published: (2017-09-01) -
AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas
by: Marko Hojnik, et al.
Published: (2020-12-01) -
Elevated Peripheral Blood Plasma Concentrations of Tie-2 and Angiopoietin 2 in Patients with Neuroendocrine Tumors
by: Henryk Stepien, et al.
Published: (2012-01-01) -
Enzymes of the AKR1B and AKR1C subfamilies and uterine diseases
by: Tea eLanisnik Rizner
Published: (2012-03-01)